The controversy over patenting genes took a new twist in February, when a
patients group got in on the act. PXE International patented methods of treating
the debilitating genetic disease PXE based on the MRP6 gene. Mutations
in MRP6 are to blame for the disease. The group hopes that owning the
gene will allow it to accelerate research, control licence fees and prevent turf
wars between scientists.
To continue reading, today with our introductory offers
Advertisement
More from Â鶹´«Ã½
Explore the latest news, articles and features
Popular articles
Trending Â鶹´«Ã½ articles
1
Are Neanderthals descendants of modern humans?
2
The brain's cleaning system can be boosted to rid Alzheimer's proteins
3
From autism to migraines, birth order may have wide-reaching effects
4
The man who crawls into the perilous heart of the Chernobyl reactor
5
The biggest threat to Chernobyl is no longer radiation
6
Exclusive report: Inside Chernobyl, 40 years after nuclear disaster
7
Particles seen emerging from empty space for first time
8
How autoimmune conditions can unexpectedly drive mental illness
9
Forget the multiverse. In the pluriverse, we create reality together
10
Largest ever map of universe captures 47 million galaxies and quasars
